Sachdev D - Search Results

1

Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression.

Zhang X, Kamaraju S, Hakuno F, Kabuta T, Takahashi S, Sachdev D, Yee D. Zhang X, et al. Among authors: sachdev d. Breast Cancer Res Treat. 2004 Jan;83(2):161-70. doi: 10.1023/b:brea.0000010709.31256.c6. Breast Cancer Res Treat. 2004. PMID: 14997047

2

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D. Sachdev D, et al. Cancer Res. 2003 Feb 1;63(3):627-35. Cancer Res. 2003. PMID: 12566306

3

A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.

Sachdev D, Hartell JS, Lee AV, Zhang X, Yee D. Sachdev D, et al. J Biol Chem. 2004 Feb 6;279(6):5017-24. doi: 10.1074/jbc.M305403200. Epub 2003 Nov 13. J Biol Chem. 2004. PMID: 14615489 Free article.

4

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.

Sachdev D, Singh R, Fujita-Yamaguchi Y, Yee D. Sachdev D, et al. Cancer Res. 2006 Feb 15;66(4):2391-402. doi: 10.1158/0008-5472.CAN-05-3126. Cancer Res. 2006. PMID: 16489046

5

Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer.

Sachdev D, Yee D. Sachdev D, et al. J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):27-39. doi: 10.1007/s10911-006-9010-8. J Mammary Gland Biol Neoplasia. 2006. PMID: 16947084 Review.

6

Disrupting insulin-like growth factor signaling as a potential cancer therapy.

Sachdev D, Yee D. Sachdev D, et al. Mol Cancer Ther. 2007 Jan;6(1):1-12. doi: 10.1158/1535-7163.MCT-06-0080. Mol Cancer Ther. 2007. PMID: 17237261 Review.

7

Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells.

Zhang H, Sachdev D, Wang C, Hubel A, Gaillard-Kelly M, Yee D. Zhang H, et al. Among authors: sachdev d. Breast Cancer Res Treat. 2009 Mar;114(2):277-85. doi: 10.1007/s10549-008-0014-5. Epub 2008 Apr 17. Breast Cancer Res Treat. 2009. PMID: 18418709

8

Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo.

Zeng X, Sachdev D, Zhang H, Gaillard-Kelly M, Yee D. Zeng X, et al. Among authors: sachdev d. Clin Cancer Res. 2009 Apr 15;15(8):2840-9. doi: 10.1158/1078-0432.CCR-08-1401. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351773 Free PMC article.

9

Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment.

Fagan DH, Uselman RR, Sachdev D, Yee D. Fagan DH, et al. Among authors: sachdev d. Cancer Res. 2012 Jul 1;72(13):3372-80. doi: 10.1158/0008-5472.CAN-12-0684. Epub 2012 May 9. Cancer Res. 2012. PMID: 22573715 Free PMC article.

10

The IGF system and breast cancer.

Sachdev D, Yee D. Sachdev D, et al. Endocr Relat Cancer. 2001 Sep;8(3):197-209. doi: 10.1677/erc.0.0080197. Endocr Relat Cancer. 2001. PMID: 11566611 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters